Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Simonetta

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Open Forum Infectious Diseases|March 4, 2026
Pretransplant CMV-IgG Titers and DNAemia Are Associated With CMV Infections Post Allogeneic Hematopoietic Cell Transplant With or Without LetermovirLéna Royston, Ming Zou, Federico Simonetta, et al.
Journal for Immunotherapy of Cancer|December 25, 2025
Influence of time-of-day of graft infusion on allogeneic hematopoietic stem cell transplantation outcomes: a validation cohort studyChiara Bernardi, Amandine Pradier, Stavroula Masouridi-Levrat, et al.
Cancer Research|September 9, 2020
Visualization of Activated T Cells by OX40-ImmunoPET as a Strategy for Diagnosis of Acute Graft-versus-Host DiseaseIsrat S Alam, Federico Simonetta, Lukas Scheller, et al.
The Journal of Biological Chemistry|February 1, 2006
DNA damage-induced expression of p53 suppresses mitotic checkpoint kinase hMps1: the lack of this suppression in p53MUT cells contributes to apoptosisMandar R Bhonde, Marie-Luise Hanski, Jan Budczies, et al.
Transplantation and Cellular Therapy|August 11, 2022
Defibrotide Shows Efficacy in the Prevention of Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective StudyYves Chalandon, Anne-Claire Mamez, Federica Giannotti, et al.
Open Forum Infectious Diseases|April 28, 2025
Blood Virome After Allogeneic Hematopoietic Stem Cell TransplantationKrisztina Hosszu-Fellous, Samuel Cordey, Stavroula Masouridi-Levrat, et al.
ACS Central Science|June 1, 2022
Multiparameter Longitudinal Imaging of Immune Cell Activity in Chimeric Antigen Receptor T Cell and Checkpoint Blockade TherapiesJinghang Xie, Fadi El Rami, Kaixiang Zhou, et al.
Journal of Leukocyte Biology|September 24, 2023
Single-cell transcriptomics reveal different maturation stages and sublineage commitment of human thymic invariant natural killer T cellsKristina Maas-Bauer, Natalie Köhler, Anna-Verena Stell, et al.
Nature Biotechnology|March 20, 2019
Engineered immune cells as highly sensitive cancer diagnosticsAmin Aalipour, Hui-Yen Chuang, Surya Murty, et al.
Blood Advances|July 24, 2024
NK- and T-cell repertoire is established early after allogeneic HSCT and is imprinted by CMV reactivationAntonia Schäfer, Zuleika Calderin Sollet, Marie-Priscille Hervé, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Open Forum Infectious Diseases|March 4, 2026
Pretransplant CMV-IgG Titers and DNAemia Are Associated With CMV Infections Post Allogeneic Hematopoietic Cell Transplant With or Without LetermovirLéna Royston, Ming Zou, Federico Simonetta, et al.
Journal for Immunotherapy of Cancer|December 25, 2025
Influence of time-of-day of graft infusion on allogeneic hematopoietic stem cell transplantation outcomes: a validation cohort studyChiara Bernardi, Amandine Pradier, Stavroula Masouridi-Levrat, et al.
Cancer Research|September 9, 2020
Visualization of Activated T Cells by OX40-ImmunoPET as a Strategy for Diagnosis of Acute Graft-versus-Host DiseaseIsrat S Alam, Federico Simonetta, Lukas Scheller, et al.
The Journal of Biological Chemistry|February 1, 2006
DNA damage-induced expression of p53 suppresses mitotic checkpoint kinase hMps1: the lack of this suppression in p53MUT cells contributes to apoptosisMandar R Bhonde, Marie-Luise Hanski, Jan Budczies, et al.
Transplantation and Cellular Therapy|August 11, 2022
Defibrotide Shows Efficacy in the Prevention of Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective StudyYves Chalandon, Anne-Claire Mamez, Federica Giannotti, et al.
Open Forum Infectious Diseases|April 28, 2025
Blood Virome After Allogeneic Hematopoietic Stem Cell TransplantationKrisztina Hosszu-Fellous, Samuel Cordey, Stavroula Masouridi-Levrat, et al.
ACS Central Science|June 1, 2022
Multiparameter Longitudinal Imaging of Immune Cell Activity in Chimeric Antigen Receptor T Cell and Checkpoint Blockade TherapiesJinghang Xie, Fadi El Rami, Kaixiang Zhou, et al.
Journal of Leukocyte Biology|September 24, 2023
Single-cell transcriptomics reveal different maturation stages and sublineage commitment of human thymic invariant natural killer T cellsKristina Maas-Bauer, Natalie Köhler, Anna-Verena Stell, et al.
Nature Biotechnology|March 20, 2019
Engineered immune cells as highly sensitive cancer diagnosticsAmin Aalipour, Hui-Yen Chuang, Surya Murty, et al.
Blood Advances|July 24, 2024
NK- and T-cell repertoire is established early after allogeneic HSCT and is imprinted by CMV reactivationAntonia Schäfer, Zuleika Calderin Sollet, Marie-Priscille Hervé, et al.
Pageof 8